In December 2012 the European Commission released the results of its public consultation on stakeholder involvement in Health Technology Assessment (HTA), as envisaged by the Directive on patients’ rights in cross-border healthcare.
Article 15 of Directive 2011/24/EU on the application of patient rights in cross-border healthcare provides for the establishment of a permanent, voluntary Health Technology Assessment (HTA) network in the EU, connecting national authorities and bodies responsible for HTA appointed by the member states. It also specifies that stakeholder consultations on the Network’s activities should take place.
In order to assess how best to structure such stakeholder involvement, the European Commission launched a public consultation between May and August 2012 - some 52 contributions were received.
In general, the respondents expressed a clear interest in the HTA network but their capacity to actively engage differs; industry respondents in general reported better access to staff, experts and financial resources than other stakeholders, whereas citizen and patient organisations reported the lowest capacity.
EPHA Related articles
European Commission consults on Art 15 voluntary network - Health Technology Assessment
EPHA Briefing on Health Technology Assessment (HTA)
Health Technology Assessments - understanding the political challenges